Citation:Horita N, Miyazawa N, Morita S, Kojima R, Kimura N, Kaneko T, et al 2013

From Cancer Guidelines Wiki

Citation


Horita N, Miyazawa N, Morita S, Kojima R, Kimura N, Kaneko T, et al. Preoperative chemotherapy is effective for stage III resectable non--small-cell lung cancer: metaanalysis of 16 trials. Clin Lung Cancer 2013 Sep;14(5):488-94 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23664722.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Horita N, Miyazawa N, Morita S, Kojima R, Kimura N, Kaneko T, et al 2013What is the clinical benefit of neoadjuvant chemotherapy for patients with stage III operable NSCLC?Professor Michael Brown MBBS PhD FRACP FRCPAcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the clinical benefit of neoadjuvant chemotherapy for patients with stage III operable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the clinical benefit of neoadjuvant chemotherapy for patients with stage III operable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Emma.dickins/Sandbox
  2. What is the clinical benefit of neoadjuvant chemotherapy for patients with stage III operable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Horita_N,_Miyazawa_N,_Morita_S,_Kojima_R,_Kimura_N,_Kaneko_T,_et_al_2013&oldid=76339"